Atlas Trials

The Appropriate Remifentanil Dose for Optimal Insertion of Laryngeal Mask Airway in Adult Patients During Induction of General Anesthesia Using Remimazolam.

Clinical trial NCT06289829 · COMPLETED

Trial details

NCT number
NCT06289829
Sponsor
Yonsei University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Adult, Laryngeal Masks, Remimazolam, Remifentanil
Start date
2024-04-04
Primary completion
2026-03-12
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.